reference/14732861

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14732861

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1932-6203
issueIdentifier	4
pageRange	e34833-
publicationName	PLoS ONE
startingPage	e34833
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9569fc20b812324133e33485380f91d8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e4dd2ce5da849da3be7b4937d4b43942 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_80daea19274c303e41fea310d591a43e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9ba51b05954aee7491254a83b6351cac http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
bibliographicCitation	Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, Nunez MI, Wistuba II, Erasmus JJ, Hicks ME, Grimm EA, Reuben JM, Baladandayuthapani V, Templeton NS, McMannis JD, Roth JA. Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans. PLoS ONE. 2012 Apr 25;7(4):e34833. doi: 10.1371/journal.pone.0034833.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe4116a761c9a5f8e524ec874c5d25d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49c835912e4078a0d274662fa245ea93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3433ef46350ecc9eb833b76a7927e05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91e18dcce49ffb7ba77a0ebf8ee09a0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e0a87f5c44a6872c78381540e7ed0d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ea0fd4ace7f84cdee1a64658009a5fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_512f2bd97e6bc702ba23fbb855e8f2fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d78e2e9faa819736a02a919c71fb1cef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d659b80eab982c8e77b1b6cc46cc119 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06d4977fe3fd98cea53fdab46c12181f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_863c48ea4cdf7e4665c83b9eedaa5806 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_233ed302224b53f202faf3a0e0d3b2ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d826d645b5ddbb322cac3ebad831ccf2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3af172b838f0055929afb0582861dcb7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cb2fe7dae66f0f9a0d114f54e783fae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92ccd05824a264b22bc8fc2ca4a78c02
date	2012-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1371/journal.pone.0034833 https://pubmed.ncbi.nlm.nih.gov/PMC3338819 https://pubmed.ncbi.nlm.nih.gov/22558101
isPartOf	https://portal.issn.org/resource/ISSN/1932-6203 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans
discusses	http://id.nlm.nih.gov/mesh/M0474216 http://id.nlm.nih.gov/mesh/M0008269 http://id.nlm.nih.gov/mesh/M0483936 http://id.nlm.nih.gov/mesh/M0374857 http://id.nlm.nih.gov/mesh/M0190949
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015316Q000379 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D025521Q000627 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D053758Q000627 http://id.nlm.nih.gov/mesh/D018014
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000644Q000008 http://id.nlm.nih.gov/mesh/D049268 http://id.nlm.nih.gov/mesh/D053758Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D010957Q000008 http://id.nlm.nih.gov/mesh/D020869 http://id.nlm.nih.gov/mesh/D017209Q000235 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D025521Q000378 http://id.nlm.nih.gov/mesh/D025521Q000008 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D005229Q000008 http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11636182 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437371 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218742 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2148ce0d6e2dc137e3c7ac232dbd64e3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10737 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dd128d4ee5873d0d4cb822e94871336d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_812be064ccd12222c26955089b06604e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129978914 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128047904 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796650

Total number of triples: 82.